GW1516 in Thailand: Endurance & Fat Metabolism Therapy
GW1516 is a PPARdelta agonist studied for its ability to enhance aerobic endurance, accelerate fat oxidation, and improve metabolic flexibility through gene expression pathways involved in fatty acid utilization. In physician-supervised protocols, it is used selectively for endurance performance support and metabolic optimization.
Doctor-prescribed GW1516 in Thailand is available at Peptides Thailand under physician supervision, with clinical-grade, COA-verified oral capsules. It is prescribed for metabolic and endurance protocols following physician assessment, most frequently considered for patients with specific body composition or performance goals.
How GW1516 Works
GW1516 operates through sophisticated pathways to enhance metabolic function and endurance capacity. Its primary mechanism involves activating PPAR-delta, a key regulator of fatty acid metabolism and energy homeostasis. The compound also demonstrates significant effects on muscle fiber composition and mitochondrial function through multiple molecular pathways.
Medical Review Status
Last reviewed: June 2026 | Next review: December 2026
Written by Dr. Michael Ackland · Medically reviewed by Dr. Ploy Pitayanon, MD, licensed by the Medical Council of Thailand
At a Glance
Peptide
GW1516
Category
Oral Peptide
Dosage
10mg
Frequency
1 capsule daily
Administration
Oral capsules
Potential Benefits
- · Enhances exercise endurance
- · Improves fat metabolism
- · Supports metabolic health
Quality Matters
Why we use Clinical-Grade only
Certificate of Analysis
Every peptide we dispense comes with a third-party COA confirming purity and potency, never grey-market sourced.
Compounded in Thailand
Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards.
Physician-prescribed only
No dispensing without a prescription. Every protocol begins with a licensed physician consultation and clinical assessment.
Medical Disclaimer
The information on this page is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Any therapies, consultations, or prescriptions are provided only following assessment by a licensed physician and where clinically appropriate. Individual results may vary and no specific outcomes are guaranteed. Certain compounds discussed may not be approved medicines registered with the Thai FDA for specific therapeutic indications. Nothing here should be interpreted as a recommendation to self diagnose, self treat, or replace consultation with a qualified healthcare professional.
Potential Benefits
Enhances exercise endurance
Improves fat metabolism
Supports metabolic health
Increases energy efficiency
Enhances athletic performance
Supports muscle function
Improves stamina
Optimizes body composition
Enhances recovery
Supports cardiovascular health
Speak with a physician
Interested in GW1516?
All protocols require a physician assessment before any prescription is issued. Book a free video consultation with an MCT-licensed doctor.
Treatment Protocol
Dosage
10mg
Frequency
1 capsule daily
Duration
8-12 weeks
Administration
Oral capsules
Safety guide
GW1516 Side Effects & Safety
Frequency, contraindications, and who is a good candidate
Recent GW1516 Research
Comprehensive Characterisation of the PPARdelta Agonist GW501516 for Doping Control
Characterised GW501516 pharmacology and developed analytical methods for detection, confirming its potent PPARdelta-mediated metabolic and endurance effects (Drug Test Anal, 2021).
View on PubMedMetabolomic Study of GW501516 for Enhancing Running Endurance in Mice
Showed GW501516 significantly increased running endurance in mice by shifting skeletal muscle metabolism toward fatty acid oxidation via PPARdelta activation (Sci Rep, 2015).
View on PubMedMetabolic Modulators of the Exercise Response: Doping Control Analysis of PPARdelta Agonist
Demonstrated GW501516 activates PPARdelta to enhance fatty acid catabolism and endurance capacity, with discussion of its metabolic modulator classification (J Physiol Pharmacol, 2014).
View on PubMedRelated Peptides
Prefer to message first?
Chat with our team on WhatsApp. We typically reply within minutes.
Chat about GW1516